Toronto Dominion Bank
IPCI

Toronto Dominion Bank’s Intellipharmaceuticals International Inc. IPCI Stock Holding History

Toronto Dominion Bank’s Portfolio IPCI Stock Details IPCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-57
Closed – – 1835
2018
Q4 		$0 Sell
57
-1,543
-96% -$949 ﹤0.01% 1735
2018
Q3 		$4K Buy
1,600
+1,596
+39,900% +$5.33K ﹤0.01% 1261
2018
Q2 		$0 Sell
4
-31
-89% -$141 ﹤0.01% 1626
2018
Q1 		$0 Buy
35
+15
+75% +$108 ﹤0.01% 1485
2017
Q4 		$0 Buy
+20
New +$182 ﹤0.01% 1357
2017
Q2 		– Hold
0
– – – 1328
2017
Q1 		– Sell
-4
Closed -$103 – 1324
2016
Q4 		$0 Buy
4
+3
+300% +$84 ﹤0.01% 1355
2016
Q3 		$0 Sell
1
-5
-83% -$90 ﹤0.01% 1292
2016
Q2 		$0 Buy
6
+2
+50% +$36 ﹤0.01% 1340
2016
Q1 		$0 Buy
4
+2
+100% +$44 ﹤0.01% 1330
2015
Q4 		$0 Sell
2
-1
-33% -$19 ﹤0.01% 1134
2015
Q3 		$0 Sell
3
-5
-63% -$131 ﹤0.01% 1152
2015
Q2 		$0 Buy
+8
New +$242 ﹤0.01% 1171

Toronto Dominion Bank's IPCI Position: Q1 2019 in Review

Toronto Dominion Bank sold out of Intellipharmaceuticals International Inc. (IPCI) in Q1 2019, closing a stake of 57 shares.

Toronto Dominion Bank first reported a position in IPCI in Q2 2015 and held it in 12 quarters. The position peaked at $4K in Q3 2018. 0 funds tracked by Wall St. Rank hold IPCI as of Q1 2019.

  • Toronto Dominion Bank reported no remaining Intellipharmaceuticals International Inc. position as of Q1 2019 after selling out during the quarter.
  • Toronto Dominion Bank sold 57 Intellipharmaceuticals International Inc. shares in Q1 2019.
  • Toronto Dominion Bank first reported a position in Intellipharmaceuticals International Inc. in Q2 2015 and held it in 12 quarters.
  • Toronto Dominion Bank's Intellipharmaceuticals International Inc. position peaked at $4K in Q3 2018.
  • 0 funds tracked by Wall St. Rank held Intellipharmaceuticals International Inc. as of Q1 2019.

Based on Toronto Dominion Bank's 13F filing for Q1 2019, filed 6 May 2019.